CKM and sarcoma: Interestingly, malignant transformation of skeletal muscle to sarcoma results in reduction of M-CK levels, indicating that M-CK supports the specific metabolic needs of skeletal myofibers, which gradually lose their differentiation status and contractile properties during sarcoma development [110].